Dustin Chernick

458 total citations
10 papers, 341 citations indexed

About

Dustin Chernick is a scholar working on Neurology, Physiology and Surgery. According to data from OpenAlex, Dustin Chernick has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Dustin Chernick's work include Alzheimer's disease research and treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Cholesterol and Lipid Metabolism (3 papers). Dustin Chernick is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Cholesterol and Lipid Metabolism (3 papers). Dustin Chernick collaborates with scholars based in United States and Germany. Dustin Chernick's co-authors include Ling Li, Shaowu Cheng, David A. Hottman, Zhe Wang, Angela Jeong, Wenhui Qu, Robert A. Hauser, Rui Zhong, Karunya K. Kandimalla and G. William Rebeck and has published in prestigious journals such as Neurology, Journal of Neurochemistry and Neurobiology of Disease.

In The Last Decade

Dustin Chernick

10 papers receiving 330 citations

Peers

Countries citing papers authored by Dustin Chernick

Since Specialization

Citations

This map shows the geographic impact of Dustin Chernick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dustin Chernick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dustin Chernick more than expected).

Fields of papers citing papers by Dustin Chernick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dustin Chernick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dustin Chernick. The network helps show where Dustin Chernick may publish in the future.

Co-authorship network of co-authors of Dustin Chernick

This figure shows the co-authorship network connecting the top 25 collaborators of Dustin Chernick. A scholar is included among the top collaborators of Dustin Chernick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dustin Chernick. Dustin Chernick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	The HDL-Mimetic Peptide 4F Mitigates Vascular and Cortical Amyloid Pathology and Associated Neuroinflammation in a Transgenic Mouse Model of Cerebral Amyloid Angiopathy and Alzheimer’s Disease 2025 ·Molecular Neurobiology ·Rui Zhong, Dustin Chernick, David A. Hottman, Yejun Tan, (unknown), (unknown), Ling Li	2
2	Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease 2021 ·Frontiers in Neurology ·Robert A. Hauser, Ryan R. Walsh, Rajesh Pahwa, Dustin Chernick, (unknown)	18
3	Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia 2021 ·Neurology and Therapy ·Robert A. Hauser, Shyamal H. Mehta, Daniel Kremens, Dustin Chernick, (unknown)	10
4	Gocovri Reduces Disruptive Motor Episodes and Improves Function in Parkinson’s Disease Patients With OFF Episodes and Dyskinesia: Analysis of Phase 3 Trial Data (1882) 2020 ·Neurology ·Robert A. Hauser, Dustin Chernick, (unknown)	3
5	EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease 2020 ·Journal of Parkinson s Disease ·Caroline M. Tanner, Rajesh Pahwa, Robert A. Hauser, Wolfgang H. Oertel, Stuart Isaacson, Joseph Jankovic, Reed Johnson, Dustin Chernick, Jean Hubble	25
6	The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease 2020 ·Biomolecules ·Dustin Chernick, Rui Zhong, Ling Li	22
7	Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier 2019 ·Neuroscience Letters ·Dustin Chernick, (unknown), Angela Jeong, Wenhui Qu, Ling Li	49
8	High‐density lipoprotein mimetic peptide 4F mitigates amyloid‐β‐induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia 2018 ·Journal of Neurochemistry ·Dustin Chernick, (unknown), Angela Jeong, Suresh Kumar Swaminathan, Karunya K. Kandimalla, G. William Rebeck, Ling Li	42
9	Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells 2016 ·ACS Chemical Biology ·Charuta C. Palsuledesai, Joshua D. Ochocki, (unknown), Yen-Chih Wang, Janel K. Warmka, Dustin Chernick, Elizabeth V. Wattenberg, Ling Li, Edgar A. Arriaga, Mark D. Distefano	30
10	HDL and cognition in neurodegenerative disorders 2014 ·Neurobiology of Disease ·David A. Hottman, Dustin Chernick, Shaowu Cheng, Zhe Wang, Ling Li	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact